Pliant Therapeutics Inc
PLRX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$53.18M
Close$
$0.27
68.3% downside
Current Fair Value
68.3% downsideOvervalued by 68.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $53.18 Million |
|---|---|
| Enterprise Value | $57.04 Million |
| Earnings per Share | $-2.43 |
| Beta | 1.28 |
| Outstanding Shares | 61,919,233 |
Return
| Return on Equity | -62.81% |
|---|---|
| Return on Assets | -48.60% |
| Return on Invested Capital | -55.57% |
Valuation & Multiples
| P/E Ratio | -0.58 |
|---|---|
| PEG | 1.19 |
| Price to Sales | - |
| Price to Book Ratio | 0.42 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.59 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.34
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.37
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 151.86% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.83%▼ 76.85% |
|---|---|
| Total Invested | $554,001▼ 98.99% |
| Investors Holding | 3▼ 85.00% |
About Pliant Therapeutics Inc
CEO: Bernard Coulie
